EFFECTIVENESS OF THE PULMONARY REHABILITATION PROGRAMME IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND OBESITY
https://doi.org/10.25207/1608-6228-2019-26-3-63-70
Abstract
Aim. To evaluate the effectiveness of pulmonary rehabilitation programme in patients with chronic obstructive pulmonary disease (COPD) and obesity.
Materials and methods. The study included two groups of patients. The first group consisted of 44 patients with COPD and obesity (23 men and 21 women; median age — 57.47±0.76 years; average body mass index (BMI) — 34.1±1.24 kg/m2) who were receiving only standard medical treatment for COPD. The second group consisted of 44 patients (22 men, 22 women; median age — 56.07±0.83 years, average BMI — 33.4±1.62 kg/m2) who were undergoing pulmonary rehabilitation along with the standard medical treatment for COPD. Pulmonary rehabilitation programme involved group training of COPD patients including dietary recommendations, graduated exercise, as well as recommendations on smoking cessation. At the initial stage and 12 months after the study, the severity of COPD symptoms was assessed using a visual analogue scale, the frequency of exacerbations and hospitalisations, spirometry parameters, as well as quality of life data obtained via the SF-36 questionnaire.
Results. At 12 months into the study, patients from the second group showed a significant decrease in the number of COPD exacerbations and related hospitalisations; a decrease in the shortness of breath, cough, sputum production; as well as an improvement of the SF-36 questionnaire with respect to a number of points. At the same time, spirometry parameters did not improve significantly.
Conclusion. Inclusion of pulmonary rehabilitation programmes in the standard treatment of patients with COPD and obesity contributes to providing higher effcacy of medical treatment, decreasing the load of main COPD clinical symptoms, as well as to reducing their impact on the patients’ health status and improving life quality.
Supporting agencies: This research was carried out under the grant of the President of the Russian Federation aimed at supporting leading scientific schools (NSh 4994.2018.7).
About the Authors
Evgeny S. Ovsyannikov
Voronezh State Medical University
Russian Federation
Russian Federation
Cand. Sci. (Med.), Assoc. Prof., Department for Intermediate Level Therapy,
Studencheskaya str., 10, Voronezh, 394036;
tel.: +7 (910) 340–52–81; Bulvar Pobedy, 1–58, Voronezh, 394077
Andrey V. Budnevsky
Voronezh State Medical University
Russian Federation
Russian Federation
Dr. Sci. (Med.), Prof., Head of Department for Intermediate Level Therapy,
Studencheskaya str., 10, Voronezh, 394036
Yanina S. Shkatova
Voronezh State Medical University
Russian Federation
Russian Federation
Postgraduate Researcher, Department for Intermediate Level Therapy,
Studencheskaya str., 10, Voronezh, 394036
References
1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of COPD. Available from: https://goldcopd.org/wp-content/uploads/2017/11/GOLD-2018-v6.0-FINAL-revised-20-Nov_WMS.pdf. Accessed 20 January 2019.
2. Aisanov Z.R., Avdeev S.N., Arkhipov V.V., Belevskiy A.S., Leshchenko I.V., Ovcharenko S.I., Shmelev E.I., Chuchalin A.G. National clinical guidelines on diagnosis and treatment of chronic obstructive pulmonary disease: a clinical decision-making algorithm. Russian Pulmonology. 2017; 27(1): 13–20 (In Russ., English abstract). DOI: 10.18093/0869-0189-
3. -27-1-13-20 3. Golpe R., Suárez-Valor M., Martín-Robles I., Sanjuán-López P., Cano-Jiménez E., Castro-Añón O., Pérez de Llano L.A. Mortality in COPD patients according to clinical phenotypes. Int.J. Chron. Obstruct. Pulmon. Dis. 2018; 1(13): 1433–1439. DOI: 10.2147/copd.s159834
4. Miravitlles M., Ribera A. Understanding the impact of symptoms on the burden of COPD. Respir. Res. 2017; 18(1): 67. DOI: 10.1186/s12931-017-0548-3
5. Chuchalin A.G., Avdeev S.N., Aysanov Z.R., Belevskiy A.S., Leshchenko I.V., Meshcheryakova N.N., Ovcharenko S.I., Shmelev E.I. Russian respiratory society. Federal guidelines on diagnosis and treatment of chronic obstructive pulmonary disease. Russian Pulmonology. 2014;(3): 15–54 (In Russ.) DOI: 10.18093/0869-0189-2014-0-3-15-54
6. Mathur S., Brooks D., Carvalho C.R. Structural alterations of skeletal muscle in copd. Front. Physiol. 2014; 5: 104. DOI: 10.3389/fphys.2014.00104
7. Gagnon P., Guenette J.A., Langer D., Laviolette L., Mainguy V., Maltais F., Ribeiro F., Saey D. Pathogenesis of hyperinflation in chronic obstructive pulmonary disease. Int.J. Chron. Obstruct. Pulmon. Dis. 2014; 9: 187–201. DOI: 10.2147/COPD.S38934.
8. Gologanu D., Ionita D., Gartonea T., Stanescu C., Bogdan M.A. Body composition in patients with chronic obstructive pulmonary disease. Maedica (Buchar). 2014; 9(1): 25–32.
9. McCarthy B., Casey D., Devane D., Murphy K., Murphy E., Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst. Rev. 2015; 2: CD003793. DOI: 10.1002/14651858.cd003793.pub3
10. Aisanov Z., Avdeev S., Arkhipov V., Belevskiy A., Chuchalin A., Leshchenko I., Ovcharenko S., Shmelev E., Miravitlles M. Russian guidelines for the management of COPD: algorithm of pharmacologic treatment. Int.J. Chron. Obstruct. Pulmon. Dis. 2018; 13: 183–187. DOI: 10.2147/copd.s153770
11. Schroff P., Hitchcock J., Schumann C., Wells J.M., Dransfeld M.T., Bhatt S.P. Pulmonary rehabilitation improves outcomes in chronic obstructive pulmonary disease independent of disease burden. Ann. Am. Thorac. Soc. 2017; 14(1): 26–32. DOI: 10.1513/AnnalsATS.201607-551OC
12. Melo L.C., Silva M.A., Calles A.C. Obesity and lung function: a systematic review. Einstein (Sao Paulo). 2014; 2(1): 120–125. DOI: 10.1590/s1679-45082014rw2691
13. Dixon A.E., Peters U. The effect of obesity on lung function. Expert. Rev. Respir. Med. 2018; 12(9): 755–767. DOI: 10.1080/17476348.2018.1506331
14. Budnevskiy A.V., Chernov A.V., Isaeva Y.V., Malysh E.Y. Сlinical effcacy of pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease and metabolic syndrome. Russian Pulmonology. 2015; 25(4): 447–455 (In Russ.) DOI: 10.18093/0869-0189-2015-25-4-447-455
15. Holland A.E., Mahal A., Hill C.J., Lee A.L., Burge A.T., Cox N.S., Moore R., Nicolson C., O’Halloran P., Lahham A., Gillies R., McDonald C.F. Home-based rehabilitation for COPD using minimal resources: a randomised, controlled equivalence trial. Thorax. 2017; 72(1): 57–65. DOI: 10.1136/thoraxjnl-2016-208514
16. Bisca G.W., Camillo C.A., Cavalheri V., Pitta F., Osadnik C.R. Peripheral muscle training in patients with chronic obstructive pulmonary disease: novel approaches and recent advances. Expert. Rev. Respir. Med. 2017; 11(5): 413–423. DOI: 10.1080/17476348.2017.1317598
17. Sava F., Laviolette L., Bernard S., Breton M.J., Bourbeau J., Maltais F. The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD. BMC Pulm. Med. 2010; 10: 55. DOI: 10.1186/1471-2466-10-55
18. Vagaggini B., Costa F., Antonelli S., De Simone C., De Cusatis G., Martino F., Santerini S., Paggiaro P. Clinical predictors of the effcacy of a pulmonary rehabilitation programme in patients with COPD. Respir. Med. 2009; 103(8): 1224–1230. DOI: 10.1016/j.rmed.2009.01.023
19. Wouters E.F.M., Wouters B.B.R. E.F., Augustin I.M. L., Houben-Wilke S., Vanfleteren L.E.G. W., Franssen F.M.E. Personalised pulmonary rehabilitation in COPD. Eur. Respir. Rev. 2018; 27(147): 170125. DOI: 10.1183/16000617.0125-2017
Review
For citations:
Ovsyannikov E.S., Budnevsky A.V., Shkatova Ya.S. EFFECTIVENESS OF THE PULMONARY REHABILITATION PROGRAMME IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND OBESITY. Kuban Scientific Medical Bulletin. 2019;26(3):63-70. (In Russ.) https://doi.org/10.25207/1608-6228-2019-26-3-63-70
Views:
660
Email this article 